Back to training


Dr Simon Clay

Options: Exploring Patients' Experiences with Depot Buprenorphine and their Motivations to Discontinue

by Insight

  • date & time

    Wed. 3 Aug 2022
    10:00 am – 11:00 am
    AEST (QLD time)

  • location


Depot buprenorphine has been a game-changing treatment for opioid dependency and has been met with great enthusiasm and acceptability by consumers and clinicians alike. This study explores what it is like to receive depot buprenorphine and to understand why some people decide to stop this treatment.  

Dr Clay is a postdoctoral research fellow at the National Drug & Alcohol Research Centre, University of New South Wales. His research explores the lived experience of drug use, the social life of bodies, and the ways marginalised individuals embody well-being in relation to ‘risky’ health-related practices. His work also focuses on the ways queer and gender diverse people use drugs, with a particular focus on the role of community, risk, and identity.

attending webinars
  • Webinars are broadcast via Zoom.
  • Hit the sign in button and launch and/or download Zoom. 
  • Once inside the webinar visit the chat icon for all questions and comments (select All panelists and attendees).
  • Visit the button called "View Options" to change the layout of the screen.
  • For best results access in your web browser.
  • For technical support during the webinar please contact ZOOM on 1800 768 027.

Sign in to webinar

Other webinars

See all training